Join Maine ACEP on Wednesday, December 12, 2018 at the Portland Regency Hotel and Spa for a 1-CME Luncheon. This activity has been designed to meet the educational needs of emergency physicians and other clinicians involved in the treatment of patients with thrombosis (Download Program Flyer). The luncheon begins at 12:00 noon.

• Sponsor: PeerView Institute
• Registration Cost: Free (includes lunch)
• Speaker: Dr. Daniel Pallin, MD, MPH, Assistant Professot of Emergency Medicine, Harvard Medical School, Research Director, Department of Emergency Medicine, Brigham and Women's Hospital
• One (1) HOUR CME for attendees

Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants

EDUCATIONAL OBJECTIVES:
Upon completion of this activity, participants will be able to:

• Discuss the limitations to existing approaches to manage direct oral anticoagulant (DOAC)–associated major bleeding and the need for universal anti–factor Xa reversal agents
• Explain the mechanism of action of currently available DOAC reversal agents and emerging universal antidotes to factor Xa inhibitors
• Identify the most recent clinical data with regard to efficacy and safety of currently available DOAC reversal agents and emerging universal antidotes to factor Xa inhibitors
• Implement currently available and emerging DOAC reversal agents in clinical practice according to the latest evidence andguidelines for patients experiencing major DOAC-associated bleeding

FACULTY:  Dr. Daniel Pallin, MD, MPH

Assistant Professor of Emergency Medicine, Harvard Medical School
Research Director, Department of Emergency Medicine, Brigham and Women’s Hospital
Boston, Massachusetts